Carl Goldfischer, Director at MAP Pharmaceuticals, Inc. (MAPP), sold 339,914 shares at $15.50 ($5.4M) on 2010-03-09, disclosed to the SEC on 2010-03-11.
Open-market sale of $5.4M MAPP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.50 | 151,424 | $2.3M | 43.7% |
| 2 | $16.03 | 134,190 | $2.2M | 40.1% |
| 3 | $16.06 | 54,300 | $872K | 16.2% |
| Total | $15.80 avg | 339,914 | $5.4M | 100% |
| Filing → |
| CBAY | SELL | 2018-03-23 | $195K | — | Filing → |
| CBAY | SELL | 2017-11-06 | $156K | — | Filing → |
| ETRM | SELL | 2017-05-31 | $23K | — | Filing → |